US 11426418
Injectable long-acting semi-solid gel formulations
granted A61KA61K31/231A61K31/415
Quick answer
US patent 11426418 (Injectable long-acting semi-solid gel formulations) held by MIRA PHARMA CORPORATION expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MIRA PHARMA CORPORATION
- Grant date
- Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/231, A61K31/415, A61K31/5575, A61K31/56